Parameter
| Biomarker | POLE2 | Full name | Polymerase Epsilon 2 | Molecular Type | Protein & signalling-pathway related |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Prognosis & therapeutic target |
| Disease | Bladder Cancer (BC) | Disease Subtypes | / | ||
| Organ | Bladder | Test Sample / Technology Platform | Tissue & cells (database analysis, Western blot, functional assays) | ||
| Pathobiological Mechanisms | Oncogenic driver via PI3K/AKT signalling; over-expression promotes BLCA cell growth and correlates with unfavorable prognosis | ||||
| Clinical Availability Status | Research verification stage: pathway mechanism defined; clinical validation required | ||||
| Notes and Dynamics | DNA-polymerase-related protein providing prognostic and targeting implications for BLCA | ||||